The goal of basic science is:

Biology

2 answers:

avanturin [10]4 years ago

7 0

Hey Chris, thanks for asking a question here on Brainly!

You Asked ➤ The goal of basic science is:

↴ OUR CHOICES ↴

A: To increase our understanding of general principles.

B: To improve a specific situation.

C: To solve a particular problem.

D: To use technology to improve quality of life.

------------------------------------------------------------------------------------

Answer ➤ A: To increase our understanding of general principles.

Explanation: One of the major goals of basic science is understand what the key principals that make it up. We learn how it functions and understand what make science part of our world.

••• HUH? WHY IS IT NOT THE OTHER CHOICES? •••

⇢ B and C: While basic science does help improve situations and solve problems, that is not the main reason why it is studied.

⇢ D: Science has helped us use more technology, but those levels are more advanced than the general basics.

I hope this answer is helpful to you, but please let me know if you have any other questions regarding it.

- Qamar

sp2606 [1]4 years ago

4 0

Answer: To increase our understanding of general principles.

Explanation:

You might be interested in

Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist

dolphi86 [110]

Protein-protein interactions within the CARMA1-BCL10-MALT1 complex:

The T-cell receptor and B-cell receptor-dependent NF-B induction and lymphocyte activation are mediated by the CBM complex, which is made up of the proteins CARMA1, BCL10, and MALT1.
Each of the proto-oncoproteins CARMA1, BCL10, and MALT1 is a somatic gain-of-function mutation or chromosomal translocation, and dysregulation of CBM signaling is a characteristic of numerous lymphoid malignancies, including Activated B-cell Diffuse Large B-cell Lymphoma.
Moreover, a number of immunological dysregulation diseases have been linked to both gain- and loss-of-function germline mutations in CBM complex proteins.
Over the past ten years, careful examination of the interactions of CBM components has yielded a wealth of detailed structural knowledge.
Here, we discuss important discoveries about the molecular nature of these protein-protein interactions that have helped the research develop a detailed understanding of how these proteins come together to form high-order filamentous CBM complexes.
Approaches to therapeutic suppression of the CBM complex have thus far centered on obstructing MALT1 protease activity in order to treat lymphoid malignancy and/or autoimmunity.
The structural effects of MALT1 protease inhibitors on significant protein-protein interactions are also reviewed in detail.